Dr Keith Watson | Director of Global Regulatory Affairs and Biologics Strategic Development

Dr Keith Watson, Director of Global Regulatory Affairs and Biologics Strategic Development, AbbVie

Keith has over 20 years of experience gained in Pharmaceutical, Manufacturing, Regulatory, Consultancy and Academic environments. Prior to joining AbbVie, he was Vice President (Technical) at PAREXEL Consulting and previous to this was a Senior Biological Products Quality Assessor at the Medicines and Health products Regulatory Agency (MHRA) in the UK.  He also has worked in manufacturing with Lonza and was Head of Bioprocessing and Technical Support at Prometic Biosciences in Cambridge, UK.  After gaining a BSc (Hons) Applied Biochemistry degree at Liverpool JM University, he was awarded a PhD in Biochemistry from Imperial College, London and spent 5 years as a post-doctoral research scientist, initially at Imperial College, London and subsequently at Ludwig Institute of Cancer Research. 


Day 1 Orphan 14th Nov @ 15:15

Global regulatory landscape for rare disease therapeutics: implications on approval and access

back to speakers